UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases

Description

In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS, and analyze biomarkers of radiation response. This work will advance the investigators' understanding of neurocognitive changes after brain SRS and help create interventions that preserve cognitive-function in brain metastases patients.

Conditions

Brain Metastases, Adult, Neurocognitive Function, Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS, and analyze biomarkers of radiation response. This work will advance the investigators' understanding of neurocognitive changes after brain SRS and help create interventions that preserve cognitive-function in brain metastases patients.

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases: Avoidance of Eloquent White Matter and Hippocampal Regions

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases

Condition
Brain Metastases, Adult
Intervention / Treatment

-

Contacts and Locations

San Diego

Moores Cancer Center, San Diego, California, United States, 92037

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patients 18 years or older
  • 2. One to three brain metastases targets, all smaller than 3 cm in diameter (intact or resected tumor bed)
  • 3. Eastern cooperative Oncology Group (ECOG) performance status 0-2 (score of 0, no symptoms; 1, mild symptoms; 2, symptomatic, \<50% in bed during the day)
  • 4. Ability to answer questions and follow commands via neurocognitive testing
  • 5. Estimated life expectancy greater than 6 months
  • 6. Pathologic confirmation of extracerebral tumor site (eg, lung, breast, prostate) from either the primary site or a metastatic lesion
  • 7. Willingness/Ability to undergo brain MRI scans
  • 8. Able to give informed consent
  • 1. Pregnant or nursing women
  • 2. Women of childbearing potential unwilling to use adequate contraception
  • 3. Inability to complete a magnetic resonance imaging scan with contrast
  • 4. Tumor directly invading the critical area to be spared (for example a patient with tumor invading a critical white matter tract; ineligible for cognitive-sparing)
  • 5. Planned chemotherapy during SRS (on the day of SRS)
  • 6. Previous whole brain radiation therapy
  • 7. Leptomeningeal metastases (ineligible for SRS)
  • 8. Metastases from primary germ cell tumor, small cell carcinoma, or primary CNS lymphoma (ineligible for SRS)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Jona Hattangadi-Gluth,

Jona Hattangadi-Gluth, MD, PRINCIPAL_INVESTIGATOR, University of California, San Diego

Study Record Dates

2024-12-31